ASRS A project from the American Society of Retina Specialists
  1. Collections
  2. Annual Meeting Talks

APX3330, an Oral Drug in Trial for DR and DME, Demonstrated a Favorable Safety and Tolerability Profile in Multiple Phase 1 and 2 Studies

  • Michael J Allingham, MD, PhD
  • Video
  • Published 2021

Related

Category: Diabetic Retinopathy

See more